{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:36:25Z","timestamp":1790976985591,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.mehy.2013.05.002","type":"journal-article","created":{"date-parts":[[2013,5,26]],"date-time":"2013-05-26T09:00:14Z","timestamp":1369558814000},"page":"202-206","source":"Crossref","is-referenced-by-count":18,"title":["Is ivabradine suitable to control undesirable tachycardia induced by dobutamine in cardiogenic shock treatment?"],"prefix":"10.1016","volume":"81","author":[{"given":"Fran\u00e7ois","family":"Roubille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Lattuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Busseuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Davy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rh\u00e9aume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Tardif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2013.05.002_b0005","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1161\/CIRCULATIONAHA.109.192065","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2013.05.002_b0010","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mehy.2013.05.002_b0210","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jacc.2012.07.011","article-title":"Hospital Patterns of Use of Positive Inotropic Agents in Patients With Heart Failure","volume":"60","author":"Partovian","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.mehy.2013.05.002_b0020","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/01.CIR.56.3.468","article-title":"The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure","volume":"56","author":"Leier","year":"1977","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2013.05.002_b0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.resuscitation.2004.01.002","article-title":"Optimal dosing of dobutamine for treating post-resuscitation left ventricular dysfunction","volume":"61","author":"Vasquez","year":"2004","journal-title":"Resuscitation"},{"key":"10.1016\/j.mehy.2013.05.002_b0030","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2165\/00003495-199345050-00003","article-title":"Inotropic support of the critically ill patient. A review of the agents","volume":"45","author":"Kulka","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.mehy.2013.05.002_b0035","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/eurheartj\/14.5.696","article-title":"Intravenous enoximone or dobutamine for severe heart failure after acute myocardial infarction: a randomized double-blind trial","volume":"14","author":"Caldicott","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mehy.2013.05.002_b0040","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0735-1097(01)01818-6","article-title":"Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure","volume":"39","author":"Silver","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2013.05.002_b0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0033-0620(05)80005-2","article-title":"Electrophysiologic and proarrhythmic effects of intravenous inotropic agents","volume":"38","author":"Tisdale","year":"1995","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.mehy.2013.05.002_b0050","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/eurheartj\/ehr311","article-title":"Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy","volume":"32","author":"Tardif","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mehy.2013.05.002_b0215","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1161\/CIRCULATIONAHA.112.000145","article-title":"New therapeutic targets in cardiology: heart failure and arrhythmia: HCN channels","volume":"127","author":"Roubille","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2013.05.002_b0060","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1476-5381.1995.tb14971.x","article-title":"Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious rats","volume":"115","author":"Gardiner","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2013.05.002_b0065","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCRESAHA.109.208041","article-title":"The role of the funny current in pacemaker activity","volume":"106","author":"DiFrancesco","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.mehy.2013.05.002_b0070","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2165\/00003495-200464160-00003","article-title":"Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease","volume":"64","author":"DiFrancesco","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.mehy.2013.05.002_b0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0009-9236(98)90153-9","article-title":"Pharmacokinetic-pharmacodynamic modeling of the effects of ivabradine, a direct sinus node inhibitor, on heart rate in healthy volunteers","volume":"64","author":"Ragueneau","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.mehy.2013.05.002_b0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000073933","article-title":"A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction","volume":"100","author":"Manz","year":"2003","journal-title":"Cardiology"},{"key":"10.1016\/j.mehy.2013.05.002_b0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurheartj\/ehn571","article-title":"Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial","volume":"30","author":"Tardif","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mehy.2013.05.002_b0090","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2013.05.002_b0230","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000112412","article-title":"The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population","volume":"110","author":"Beautiful Study Group","year":"2008","journal-title":"Cardiology"},{"key":"10.1016\/j.mehy.2013.05.002_b0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1358\/dot.2008.44.3.1193864","article-title":"Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases","volume":"44","author":"Tardif","year":"2008","journal-title":"Drugs Today"},{"key":"10.1016\/j.mehy.2013.05.002_b0105","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00392-012-0436-2","article-title":"Lasting reduction of heart transplant tachycardia with ivabradine is effective and well tolerated: results of 48-month study","volume":"101","author":"Zhang","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.mehy.2013.05.002_b0110","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00392-008-0690-5","article-title":"Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia","volume":"97","author":"Zhang","year":"2008","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.mehy.2013.05.002_b0115","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000318530","article-title":"Cardiogenic shock due to tachycardiomyopathy after heart transplantation: successful treatment with ivabradine","volume":"116","author":"Zwicker","year":"2010","journal-title":"Cardiology"},{"key":"10.1016\/j.mehy.2013.05.002_b0120","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1016\/j.transproceed.2010.05.125","article-title":"Safety and effectiveness of ivabradine after cardiac transplantation","volume":"42","author":"Lage-Galle","year":"2010","journal-title":"Transpl Proc"},{"key":"10.1016\/j.mehy.2013.05.002_b0125","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.hrthm.2010.05.034","article-title":"Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia","volume":"7","author":"Calo","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.mehy.2013.05.002_b0130","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/europace\/euq390","article-title":"Single centre experience of ivabradine in postural orthostatic tachycardia syndrome","volume":"13","author":"McDonald","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.mehy.2013.05.002_b0135","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00392-009-0038-9","article-title":"Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure","volume":"98","author":"Link","year":"2009","journal-title":"Clinical Res Cardiol"},{"key":"10.1016\/j.mehy.2013.05.002_b0140","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00392-010-0208-9","article-title":"Use of ivabradine in catecholamine-induced tachycardia after high-risk cardiac surgery","volume":"99","author":"Vitale","year":"2010","journal-title":"Clinical Res Cardiol"},{"key":"10.1016\/j.mehy.2013.05.002_b0145","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00392-011-0323-2","article-title":"Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial","volume":"100","author":"Nuding","year":"2011","journal-title":"Clinical Res Cardiol"},{"key":"10.1016\/j.mehy.2013.05.002_b0150","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF00878087","article-title":"Electropharmacology of the bradycardic agents alinidine and zatebradine (UL-FS 49) in a conscious canine ventricular arrhythmia model of permanent coronary artery occlusion","volume":"9","author":"Aidonidis","year":"1995","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.mehy.2013.05.002_b0155","first-page":"58","article-title":"Haemodynamic and electrophysiologic actions of alinidine in the dog","volume":"244","author":"Traunecker","year":"1980","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.mehy.2013.05.002_b0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0735-1097(94)90526-6","article-title":"Zatebradine, a specific bradycardic agent, enhances the positive inotropic actions of dobutamine in ischemic myocardium","volume":"23","author":"Wynsen","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2013.05.002_b0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0014-2999(96)00688-7","article-title":"Increases in inotropic state without change in heart rate: combined use of dobutamine and zatebradine in conscious dogs","volume":"316","author":"Hettrick","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2013.05.002_b0170","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1399-6576.1997.tb04799.x","article-title":"Role of zatebradine and propranolol in attenuation of tachycardia produced by dobutamine in pigs","volume":"41","author":"Neustein","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.mehy.2013.05.002_b0225","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.athoracsur.2009.04.009","article-title":"Cardiac vagal stimulation eliminates detrimental tachycardia effects of dobutamine used for inotropic support","volume":"88","author":"Zhang","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.mehy.2013.05.002_b0180","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000322905","article-title":"Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis","volume":"117","author":"Busseuil","year":"2010","journal-title":"Cardiology"},{"key":"10.1016\/j.mehy.2013.05.002_b0185","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/HYPERTENSIONAHA.111.183913","article-title":"Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and beta-receptor blockade","volume":"59","author":"Becher","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2013.05.002_b0190","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.mehy.2012.07.006","article-title":"Could heart rate play a role in pericardial inflammation?","volume":"79","author":"Khoueiry","year":"2012","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2013.05.002_b0195","doi-asserted-by":"crossref","first-page":"H2081","DOI":"10.1152\/ajpheart.00706.2011","article-title":"Heart rate-associated mechanical stress impairs carotid but not cerebral artery compliance in dyslipidemic atherosclerotic mice","volume":"301","author":"Bolduc","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.mehy.2013.05.002_b0200","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bjp.2008.116","article-title":"Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice","volume":"154","author":"Drouin","year":"2008","journal-title":"Br J Pharmacol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713002314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713002314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T19:27:54Z","timestamp":1539631674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987713002314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0306987713002314"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2013.05.002","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}